2m 2m 2m 2m 2m 2m 2m
Ocular Therapeut (OCUL)
NASDAQ
$6.70+$0.09 (+1.36%)
Price as of Nov 11, 2026 7:30 PM EST- $1.5BMarket Cap
- -41.09%1-Year Change
- BiotechnologyIndustry
Ocular Therapeut (OCUL)
$6.70+$0.09 (+1.36%)
OCUL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.61 | ||
Change | -$0.24 (-3.50%) | ||
Open | $6.86 | ||
High | $6.87 | ||
Low | $6.60 | ||
Previous Close | $6.85 | ||
Volume | 2,657,535 | ||
30-Day Average Volume | 2,851,085 | ||
1-Week Change | -3.08% | ||
1-Month Change | -12.33% | ||
1-Year Change | -41.09% | ||
3-Year Change | 214.01% | ||
5-Year Change | -8.58% | ||
Fundamentals | |||
Shares Outstanding | 219.6M | ||
Total Assets | $605.6M | ||
Market Cap | $1.5B | ||
Enterprise Value | $994.6M | ||
Period: QTR TTM FY | |||
Revenue | $12.9M | ||
Net Income | -$94.8M | ||
Free Cash Flow | -$68.7M | ||
EBIT | -$94.8M | ||
EBITDA | -$92.4M | ||
Net Working Capital | $511.6M | ||
EPS | -$0.42 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 77 | ||
P/B | 3 | ||
P/E | -16 | ||
PEG | 1 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue